Biomedical Engineering

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More

Researchers led by John T. Wilson, associate professor of chemical and biomolecular engineering and biomedical engineering, have developed a new approach using a molecularly designed nanobody platform that seeks to make immunotherapy more effective in the treatment of cancer. The research, “Potentiating Cancer Immunotherapies with Modular Albumin-Hitchhiking Nanobody-STING… Read More